生物假体与机械假体在年龄在50-70岁的患者接受大动脉置换手术:从倾向性得分匹配结果分析结果
William A Courtney1,2, Primero Ng2,3, Charley Budgeon4
1Medical School, University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia.
European heart journal open
|February 2, 2026
概括
对于50-70岁的接受大动脉置换手术 (SAVR) 的患者,机械与生物假体相比,与较低的死亡率和主要心血管不良事件 (MACE) 有关. 然而,机械门也显示出更高的重大出血风险.
科学领域:
- 心血管外科心血管外科
- 生物材料科学 生物材料科学
- 临床结果研究研究
背景情况:
- 生物假体门越来越多地用于为70岁或更年轻的患者进行大动脉门置换手术 (SAVR).
- 在这个人口群体中,生物假肢与机械门的比较好处仍然不确定.
- 这项研究解决了对澳大利亚一组人群的比较数据的需求.
研究的目的:
- 为了比较机械门和生物假体门之间的死亡率和其他临床结果,在接受SAVR的50至70岁的患者中.
- 分析所有原因死亡率,心血管死亡率,主要不良心血管事件 (MACE),主要出血和出院生存日 (DAOH) 的差异.
主要方法:
- 来自西澳大利亚公立医院 (2010-2020年) 的相关行政结果数据与心脏门手术的前性数据收集.
- 分析包括50-70岁的患者,他们接受了SAVR.
- 倾向性得分匹配用于在初始队列选择 (n=706) 后,比较机械 (n=149) 和生物假体 (n=149) 门组之间的结果.
主要成果:
- 机械门与明显较低的全因死亡率 (aHR0.51;P=0.04) 和MACE (aHR 0.53;P=0.03) 在3.6年的中位随访期间有关.
- 使用机械门观察到更高的严重出血风险 (aHR 3.40;P=0.01).
- 在心血管死亡率,非致命性心肌梗塞,非致命性中风或假肢类型之间在医院外活着的日子方面没有发现显著差异.
结论:
- 在接受SAVR的50-70岁的患者中,机械门与生物假体门相比,具有较低的全因死亡率和MACE风险.
- 机械的观察到的好处伴随着大出血的风险增加.
- 随机对照试验是必要的,以最终证实这些发现,并指导临床决策.
更多相关视频
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
237
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
237
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
701
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
701
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
261
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
261
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
215
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
215
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
254
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
254
Sign Test for Matched Pairs
411
The sign test for matched pairs offers a robust method for comparing two paired samples, often for the effects of an intervention in one of them. This method is very useful in situations where the underlying distribution of the data is unknown. The test compares two related samples—often pre- and post-treatment measurements on the same subjects—to determine if there are significant differences in their median values.
To conduct the sign test, we first calculate the differences in...
To conduct the sign test, we first calculate the differences in...
411


